Page 10 – Linking laboratory testing to improved patient outcomes
Dr Phillip Monaghan
References
- Rohr UP, Binder C, Dieterle T, Giusti F, Messina CG, Toerien E et al. The value of in vitro diagnostic testing in medical practice: a status report. PLoS One 2016;11:e0154008.
- Monaghan PJ, Robinson S, Rajdl D, Bossuyt PM, Sandberg S, St John A et al. Practical guide for identifying unmet clinical needs for biomarkers. EJIFCC 2018;29:129–137.
- Monaghan PJ, Lord SJ, St John A, Sandberg S, Cobbaert CM, Lennartz L et al. Biomarker development targeting unmet clinical needs. Clin Chim Acta 2016;420:211–219.
- Horvath AR, Lord SJ, St John A, Sandberg S, Cobbaert CM, Lorenz S et al. From biomarkers to medical tests: the changing landscape of test evaluation. Clin Chim Acta 2014;427:49–57.
- Sandberg S, Fraser CG, Horvath AR, Jansen R, Jones G, Oosterhuis W et al. Defining analytical performance specifications: consensus statement of the 1st strategic conference of the European Federation of Clinical Chemistry and Laboratory Medicine. Clin Chem Lab Med 2015;53:833–835.
- Horvath AR, Bossuyt PM, Sandberg S, St John A, Monaghan PJ, Verhagen-Kamerbeek WD et al. Setting analytical performance specifications based on outcome studies – is it possible? Clin Chem Lab Med 2015;53:841–848.
- Karon BS, Boyd, JC, Klee GG. Glucose meter performance criteria for tight glycaemic control estimated by simulation modelling. Clin Chem 2010;56:1091–1097.
- Verbakel JY, Turner PJ, Thompson MJ, Plüddemann A, Price CP, Shinkins B et al. Common evidence gaps in point-of-care diagnostic test evaluation: a review of horizon scan reports. BMJ Open 2017;7:e015760.